Home›People›Adrienne Graves
AG

Adrienne Graves

Director at Harrow. Also a director at Qlaris Bio, Opus Genetics and TherOptix.

DirectorPublic companyRoles at 3 startups
Updated Nov 10, 2026·Latest SEC filing Jun 22, 2026·Suggest an edit

About Adrienne Graves

Adrienne Graves is a director at Harrow.

Form D filings name Adrienne Graves as a director at Qlaris Bio, Opus Genetics and TherOptix.

Adrienne Graves reports to the SEC as a director of 6 public companies, including Ocular Therapeutix (OCUL), Opus Genetics (IRD) and IVERIC bio (ISEE).

Adrienne Graves first appears on SEC filings in 2006.

Experience

This experience comes from Adrienne Graves's profile and from SEC filings. For roles taken from filings, the years are when the filings name Adrienne Graves in the role, so the role may have started earlier or lasted longer.

Harrow, Inc. Current
Board Member, Independent Director
2024 – Present · Public company (HROW)
Ocular Therapeutix, Inc. Current
Board Member, Independent Director
2023 – Present · Public company (OCUL)
NVasc Current
Board Member, Independent Director
2023 – Present
JelliSee Current
Member Board of Directors
2023 – Present
Opus Genetics Inc. Current
Director
2022 – Present · Public company (IRD)
RD Fund Current
Board Chair
2020 – Present
Qlaris Bio, Inc. Current
Independent Director
2019 – Present · Dedham, MA
Develops glaucoma treatments for patients with the eye disease.
Glaucoma Research Foundation Current
Board Member
2007 – Present
American Academy of Ophthalmology Current
Board Member (Emeritus)
2007 – Present
Brown University Medical School Current
Corporation Committee
2006 – Present
Osanni Bio
Board Member, Independent Director
2024 – 2026
Implandata Ophthalmic Products
Board Member, Independent Director
2023 – 2026
Surface Ophthalmics
Board Member
2017 – 2025
American Society of Cataract and Refractive Surgery
Board Member
2009 – 2025
IVERIC bio, Inc.
Chairman of the Board
2018 – 2024 · Public company (ISEE)
Nicox
Member Board of Directors; Chair Nominating/Governance Committee
2014 – 2024
TherOptix, Inc.
Independent Director
2019 – 2023 · Needham, MA
Greenbrook TMS NeuroHealth Centers
Board Member
2018 – 2023
Oxurion NV
Board Of Directors
2018 – 2023
Akorn Inc.
Member Board of Directors; Chair Compensation Committee
2012 – 2019 · Public company (AKRXQ)
TearLab Corp
Director
2006 – 2016 · Public company (TEAR)

Key Colleagues at Startups

The people Adrienne Graves works with at each company, as listed on that company's latest Form D.

Qlaris Bio, Inc. · Form D, Jun 17, 2026
BW
Barbara Wirostko
Executive officer
WH
Wende Hutton
Director
RW
FG
Frederic Guerard
President and Chief Executive Officer, director
RH
Ronald Hunt
Director
Opus Genetics Inc. · Form D, Jun 27, 2023
JB
Jean Bennett
Director
RK
BY
Benjamin Yerxa
President and CEO, director
TherOptix, Inc. · Form D/A, Jun 12, 2023
MM
Monty Montoya
Chief Executive Officer and director
DK
TS
JC
MA
Michael Aceti
Executive officer

Sources

  1. SECQlaris Bio, Inc. Form D, filed Jun 17, 2026
  2. SECOpus Genetics Inc. Form D, filed Jun 27, 2023
  3. SECTherOptix, Inc. Form D/A, filed Jun 12, 2023
  4. SECForms 3, 4 and 5 filed by Adrienne Graves (SEC filer 1326192)